Literature DB >> 15653285

High-dose quetiapine in treatment refractory schizophrenia.

Joseph M Pierre, Donna A Wirshing, William C Wirshing, J Michael Rivard, Russell Marks, John Mendenhall, Karen Sheppard, David G Saunders.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15653285     DOI： 10.1016/j.schres.2004.07.014

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  8 in total

1.  Quetiapine at high doses for the treatment of refractory schizophrenia.

Authors:  Douglas L Boggs; Deanna L Kelly; Stephanie Feldman; Robert P McMahon; Matthew W Nelson; Yang Yu; Robert R Conley
Journal:  Schizophr Res       Date:  2008-02-20       Impact factor: 4.939

2.  Case reports of patients with treatment-resistant schizophrenia and related psychotic disorders intolerant to clozapine responding to high doses of quetiapine.

Authors:  Poornima Chandrappa; Luk Ho
Journal:  Ther Adv Psychopharmacol       Date:  2012-10

3.  Use of high doses of quetiapine in bipolar disorder episodes are not linked to high activity of cytochrome P4503A4 and/or cytochrome P4502D6.

Authors:  Yasser Khazaal; Martin Preisig; Anne Chatton; Nadine Kaufmann; Romain Bilancioni; Chin B Eap
Journal:  Psychiatr Q       Date:  2013-09

4.  Serotonin2A receptor blockade and clinical effect in first-episode schizophrenia patients treated with quetiapine.

Authors:  Hans Rasmussen; Bjorn H Ebdrup; David Erritzoe; Bodil Aggernaes; Bob Oranje; Jan Kalbitzer; Lars H Pinborg; William F C Baaré; Claus Svarer; Henrik Lublin; Gitte M Knudsen; Birte Glenthoj
Journal:  Psychopharmacology (Berl)       Date:  2010-07-08       Impact factor: 4.530

5.  Quetiapine dosage across diagnostic categories.

Authors:  Yasser Khazaal; Anne Chatton; Riaz Khan; Daniele Zullino
Journal:  Psychiatr Q       Date:  2009-01-14

6.  Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part II.

Authors:  R Miller
Journal:  Curr Neuropharmacol       Date:  2009-12       Impact factor: 7.363

Review 7.  Quetiapine: dose-response relationship in schizophrenia.

Authors:  Anna Sparshatt; Sarah Jones; David Taylor
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

8.  High-dose quetiapine and therapeutic monitoring.

Authors:  Hervé Javelot; Francis Rangoni; Luisa Weiner; Bruno Michel
Journal:  Eur J Hosp Pharm       Date:  2018-08-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.